Friends of Cancer Research (Friends) is proud to announce a new virtual meeting, Future in Focus: Digital Pathology in Oncology Drug Development.

Friends has assembled a multi-stakeholder group to discuss opportunities for the use of digital pathology and artificial intelligence (AI)/machine learning (ML) in oncology drug development. This meeting will highlight challenges in current drug and diagnostic co-development and the unique clinical, scientific, and regulatory challenges to use of digital pathology. The panel discussion and white paper will outline proposals to facilitate robust development of digital pathology tools.

Agenda

12:00PM: Welcoming Remarks 

• Jeff Allen, President & CEO, Friends of Cancer Research

12:05PM: Presentation on Patient Selection in Oncology Drug Development and the Role of Digital Pathology

• J. Carl Barrett, University of North Carolina at Chapel Hill

12:15PM: Panel Discussion and Audience Q&A

• Kimary Kulig, Kulig Consulting & My Biomarker Navigator™ — Moderator
• Megan Doyle, Amgen
• Brandon Gallas, U.S. FDA
• Jochen Lennerz, Massachusetts General Hospital
• Mike Montalto, PathAI
• Martin Stumpe, Tempus Labs, Inc.

1:00PM: Concluding Remarks